ATE231184T1 - Impfstoffe gegen die pest - Google Patents

Impfstoffe gegen die pest

Info

Publication number
ATE231184T1
ATE231184T1 AT96905956T AT96905956T ATE231184T1 AT E231184 T1 ATE231184 T1 AT E231184T1 AT 96905956 T AT96905956 T AT 96905956T AT 96905956 T AT96905956 T AT 96905956T AT E231184 T1 ATE231184 T1 AT E231184T1
Authority
AT
Austria
Prior art keywords
pct
antigen
pestis
whole
vaccine
Prior art date
Application number
AT96905956T
Other languages
English (en)
Inventor
Richard William Titball
Ethel Diane Williamson
Sophie Emma Clare Leary
Petra Claire Farquhar Oyston
Alice Marie Bennett
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267623&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE231184(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9505059.7A external-priority patent/GB9505059D0/en
Priority claimed from GBGB9518946.0A external-priority patent/GB9518946D0/en
Priority claimed from GBGB9524825.8A external-priority patent/GB9524825D0/en
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of ATE231184T1 publication Critical patent/ATE231184T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96905956T 1995-03-13 1996-03-13 Impfstoffe gegen die pest ATE231184T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9505059.7A GB9505059D0 (en) 1995-03-13 1995-03-13 Vaccines
GBGB9518946.0A GB9518946D0 (en) 1995-09-15 1995-09-15 Vaccines
GBGB9524825.8A GB9524825D0 (en) 1995-12-05 1995-12-05 Vaccines
PCT/GB1996/000571 WO1996028551A1 (en) 1995-03-13 1996-03-13 Vaccines for plague

Publications (1)

Publication Number Publication Date
ATE231184T1 true ATE231184T1 (de) 2003-02-15

Family

ID=27267623

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96905956T ATE231184T1 (de) 1995-03-13 1996-03-13 Impfstoffe gegen die pest

Country Status (12)

Country Link
US (1) US5985285A (de)
EP (1) EP0815235B1 (de)
JP (1) JP3813173B2 (de)
CN (1) CN1155707C (de)
AT (1) ATE231184T1 (de)
AU (1) AU710181B2 (de)
CA (1) CA2215203C (de)
DE (1) DE69625802T2 (de)
DK (1) DK0815235T3 (de)
ES (1) ES2185762T3 (de)
PT (1) PT815235E (de)
WO (1) WO1996028551A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3633933B2 (ja) * 1992-07-31 2005-03-30 アカンビス、リサーチ、リミテッド 弱毒化細菌における組換え融合タンパク質の発現
WO1998024912A2 (en) * 1996-12-04 1998-06-11 Heska Corporation Recombinant plague vaccine
US6544522B1 (en) * 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US7390619B1 (en) * 1998-02-11 2008-06-24 Maxygen, Inc. Optimization of immunomodulatory properties of genetic vaccines
US6541011B2 (en) * 1998-02-11 2003-04-01 Maxygen, Inc. Antigen library immunization
US6413768B1 (en) * 1998-12-02 2002-07-02 University Of Maryland Expression plasmids
WO2000056361A2 (en) * 1999-03-24 2000-09-28 The Secretary Of State For Defence Vaccine composition
US7919119B2 (en) * 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6395300B1 (en) 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6610317B2 (en) 1999-05-27 2003-08-26 Acusphere, Inc. Porous paclitaxel matrices and methods of manufacture thereof
JP2003509046A (ja) * 1999-09-10 2003-03-11 イギリス国 組換え微生物
GB9921275D0 (en) * 1999-09-10 1999-11-10 Secr Defence Recombinant microorganisms
EP1265598B1 (de) * 2000-03-22 2006-08-02 The Secretary of State for Defence Arzneimittel zur verabreichung an schleimhäute
US20030219737A1 (en) * 2000-03-28 2003-11-27 Bullard James M. Novel DNA polymerase III holoenzyme delta subunit nucleic acid molecules and proteins
JP2004535796A (ja) * 2001-05-14 2004-12-02 レプリダイン・インコーポレーテッド エルシニア・ペスティス（ｙｅｒｓｉｎｉａｐｅｓｔｉｓ）及びシュードモナス・エルギノーサ（ｐｓｅｕｄｏｍｏｎａｓａｅｒｕｇｉｎｏｓａ）のｄｎａ複製をブロックする薬剤の開発のためのシステム
RU2190424C1 (ru) * 2001-07-18 2002-10-10 Научно-исследовательский институт микробиологии Министерства обороны Российской Федерации Антигенный состав чумной химической вакцины
CA2463008A1 (en) * 2001-10-26 2003-07-24 Id Biomedical Corporation Of Washington Efficient protein expression system
GB0220257D0 (en) 2002-08-31 2002-10-09 Secr Defence Vaccine
GB0300885D0 (en) * 2003-01-15 2003-02-12 Secr Defence Pharmaceutical composition
US7344718B2 (en) * 2003-01-31 2008-03-18 University Of North Dakota Yersinia species compositions
ES2615169T3 (es) 2003-10-22 2017-06-05 Id Biomedical Corporation Of Quebec Composiciones y procedimientos de activación de la inmunidad innata y alérgica
WO2005056769A2 (en) * 2003-12-09 2005-06-23 Avant Immunotherapeutics, Inc. Orally-administered live bacterial vaccines for plague
WO2006060728A2 (en) * 2004-12-02 2006-06-08 University Of Chicago Methods and compositions involving lcrv proteins
JP5094407B2 (ja) 2004-12-16 2012-12-12 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ Ｙｅｒｓｉｎｉａｐｅｓｔｉｓの免疫療法におけるフラジェリンの使用
CN101094685B (zh) * 2004-12-16 2016-01-13 韦克福里斯特大学健康科学院 鞭毛蛋白在鼠疫耶尔森氏菌的免疫疗法中的用途
CN101337069B (zh) * 2005-11-25 2012-07-25 中国药品生物制品检定所 复合鼠疫疫苗及其制备方法
GB0525213D0 (en) * 2005-12-12 2006-01-18 Secr Defence Vaccine
US7815911B1 (en) * 2006-10-10 2010-10-19 University Of Kentucky Research Foundation Compositions and methods for treating Yersinia pestis infection
US10174100B1 (en) * 2006-11-06 2019-01-08 Microvax, Llc Multivalent DNA composition for Yersinia pestis
US8404252B2 (en) * 2007-07-11 2013-03-26 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
GB0717187D0 (en) * 2007-09-04 2007-10-17 Novartis Ag Compositions comprising yersinia pestis antigens
CN101531710B (zh) * 2009-04-24 2012-05-09 中国疾病预防控制中心传染病预防控制所 rF1抗原及其制备方法与应用
CN101985610A (zh) * 2010-10-26 2011-03-16 中国人民解放军军事医学科学院微生物流行病研究所 一种伤寒沙门氏菌菌蜕、制备方法及作为递送系统的应用
CN101979504A (zh) * 2010-10-26 2011-02-23 中国人民解放军军事医学科学院微生物流行病研究所 鼠疫耶尔森氏菌菌蜕、其制备方法及作为疫苗的应用
WO2012178078A2 (en) 2011-06-22 2012-12-27 University Of North Dakota Use of yscf, truncated yscf and yscf homologs as adjuvants
JP6216371B2 (ja) * 2012-05-23 2017-10-18 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ ＹｅｒｓｉｎｉａｐｅｓｔｉｓＦ１−Ｖ融合タンパク質を発現するＳａｌｍｏｎｅｌｌａＴｙｐｈｉＴｙ２１ａおよびその使用
US9328149B2 (en) 2013-07-12 2016-05-03 The Catholic University Of America Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines
CN106606775A (zh) * 2015-10-27 2017-05-03 格里菲斯大学 脂质体a群链球菌疫苗
RU2671525C2 (ru) * 2015-12-07 2018-11-01 Российская Федерация, от имени которой выступает Министерство обороны Российской Федерации Рекомбинантный вакцинный препарат пролонгированного действия для профилактики чумы у млекопитающих и человека и способ его получения
US12528882B2 (en) 2019-09-13 2026-01-20 The University Of Chicago Methods and compositions for treating staphylococcal infections
CN114560932B (zh) * 2022-02-18 2023-09-12 中国人民解放军军事科学院军事医学研究院 一株鼠疫中和抗体及其应用

Also Published As

Publication number Publication date
US5985285A (en) 1999-11-16
AU4951196A (en) 1996-10-02
CN1184505A (zh) 1998-06-10
CA2215203A1 (en) 1996-09-19
EP0815235A1 (de) 1998-01-07
DK0815235T3 (da) 2003-04-22
DE69625802D1 (de) 2003-02-20
PT815235E (pt) 2003-06-30
DE69625802T2 (de) 2003-11-13
AU710181B2 (en) 1999-09-16
EP0815235B1 (de) 2003-01-15
CN1155707C (zh) 2004-06-30
JPH11501654A (ja) 1999-02-09
JP3813173B2 (ja) 2006-08-23
CA2215203C (en) 2008-12-09
WO1996028551A1 (en) 1996-09-19
ES2185762T3 (es) 2003-05-01

Similar Documents

Publication Publication Date Title
DE69625802D1 (de) Impfstoffe gegen die pest
Anderson et al. Enhancement of a secondary antibody response to vesicular stomatitis virus" G" protein by IFN-gamma treatment at primary immunization.
RU94046232A (ru) Вакцинная композиция, применение композиции, способы лечения, способ приготовления композиции
DE69327656D1 (de) Impfstoffe gegen die aujeskyskrankheit und sonstige tierkrankheiten, die pseudorabies virusmutanten enthalten
KR970707281A (ko) 풀리뉴클레오티드 결핵 백신(A polynucleotide tuberculosis vaccine)
RU94045898A (ru) Вакцинная композиция, способ стимулирования иммунной системы
FI944676A0 (fi) Rokotteita, jotka sisältävät ionisoitumattomia pinta-aktiivisten aineiden vesikkeleitä
DE69309479D1 (de) Markiertes monocyte-chemoattractant-proteinmaterial und medizinische anwendung
KR960700746A (ko) 헬리코박터 피롤리 관련 위십이지장 질환의 치료 방법(treatment of h. pylori associated gastroduodenal disease)
CA2014033A1 (en) Compositions and treatments for pneumonia in animals
ATE320444T1 (de) Peptide, die die zytotoxische t-lymphozyte antwort gegen hepatitis-b-virus induzieren
FI924457A0 (fi) Kompositioner och behandlingsfoerfarande foer lunginflammation i djur
DE60004334D1 (de) Impfstoffzusammensetzung auf basis von partikeln
DE69230855D1 (de) System der bereitstellung eines impfstoffes auf peptidbasis, das sein eigenes adjuvans bildet, und seine herstellung
DE69633233D1 (de) Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus
ATE129900T1 (de) Anwendung von il-4 zur steigerung der immunantwort auf immunogene in impfstoffen.
EA200300535A1 (ru) Способ получения антигенных структур, усиливающих специфическую перекрестную реактивность
ATE205397T1 (de) Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen
RU2039569C1 (ru) Способ профилактики бруцеллеза и кампилобактериоза крупного рогатого скота
RU2190424C1 (ru) Антигенный состав чумной химической вакцины
ATE297985T1 (de) Orale impfstoffe gegen yersinia pestis infektionen
Whyte et al. Leucocyte entry and endothelial E-selectin expression following intradermal Propionibacterium acnes administration
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
CECIL Immunization against pneumonia
Mukerjee et al. Effect of adjuvants on immunization with dengue virus-induced cytotoxic factor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0815235

Country of ref document: EP